Interim report April-June 2026

Revenue amounted to EUR 640.4 million (EUR 596.7 million), an increase of 7.3% with an organic growth of 11.8%.
Operating profit (EBIT) was EUR 51.2 million (EUR 41.7 million), an increase of 22.6% representing an operating margin of 8.0% (7.0%).
Net profit amounted to EUR 23.9 million (EUR 18.0 million), an increase of 32.1%, which represents a margin of 3.7% (3.0%).
EBITDA was EUR 106.8 million (EUR 96.2 million), an increase of 11.1%. EBITDA margin was 16.7% (16.1%).
EBITDAaL amounted to EUR 72.7 million (EUR 64.5 million), an increase by 12.6%, corresponding to an EBITDAaL margin of 11.3% (10.8%).
Net cash flow from operating activities was EUR 73.6 million (EUR 57.3 million).
Basic/diluted earnings per share were EUR 0.161 (EUR 0.127).

11.8%

Organic revenue growth

16.7%

EBITDA margin

EUR 73.6m

Operating cash flow

Revenue and earnings

EUR million	Q2 2026	Q2 2025	∆	6M 2026	6M 2025	∆	LTM	FY 2025
Revenue	640.4	596.7	7%	1,264.6	1,174.8	8%	2,467.9	2,378.1
Operating profit (EBIT)	51.2	41.7	23%	97.9	77.7	26%	175.9	155.7
Operating profit margin	8.0%	7.0%		7.7%	6.6%		7.1%	6.5%
Net profit	23.9	18.0	32%	44.5	36.8	21%	80.4	72.7
Net profit margin	3.7%	3.0%		3.5%	3.1%		3.3%	3.1%
Basic earnings per share, €	0.161	0.127	27%	0.308	0.261	18%	0.561	0.514
Diluted earnings per share, €	0.161	0.127	27%	0.306	0.260	18%	0.560	0.513
EBITDA	106.8	96.2	11%	208.0	182.7	14%	396.3	371.0
EBITDA margin	16.7%	16.1%		16.5%	15.6%		16.1%	15.6%
Adjusted EBITDA	109.2	100.9	8%	213.8	191.5	12%	410.4	388.1
Adjusted EBITDA margin	17.1%	16.9%		16.9%	16.3%		16.6%	16.3%
EBITDAaL	72.7	64.5	13%	140.1	120.8	16%	262.4	243.1
EBITDAaL margin	11.3%	10.8%		11.1%	10.3%		10.6%	10.2%
Adjusted EBITDAaL	75.1	69.2	9%	145.9	129.6	13%	276.5	260.2
Adjusted EBITDAaL margin	11.7%	11.6%		11.5%	11.0%		11.2%	10.9%
EBITA	54.1	45.7	18%	103.6	84.9	22%	189.3	170.6
EBITA margin	8.4%	7.7%		8.2%	7.2%		7.7%	7.2%

Definition and reconciliation of alternative performance measures are available at medicover.com
LTM: last twelve months (1 July 2025 - 30 June 2026)

Medicover is a leading international healthcare and diagnostic services company and was founded in 1995. Medicover operates a large number of ambulatory clinics, hospitals, specialty-care facilities, laboratories and blood-drawing points and the largest markets are Poland, Germany, Romania and India. In 2025, Medicover had revenue of EUR 2,378 million and more than 49,000 employees. For more information, go to www.medicover.com